Scott Blood

Scott Blood has a strong background in quality assurance and regulatory affairs within the medical and life sciences industry. Scott most recently served as the Vice President of Quality Assurance & Regulatory Affairs at T2 Biosystems since 2023. Prior to this, Scott was the Director of Regulatory Services at MEDIcept from 2019 to 2023. Scott also held the position of Vice President of Quality Assurance and Regulatory Affairs at Solace Therapeutics from 2016 to 2019. Before that, Scott worked as a Consultant in quality and regulatory consulting for the life sciences community from 2015 to 2016. Scott served as the Senior Director of Quality Assurance & Regulatory at NinePoint Medical from 2011 to 2015, and as the Vice President of Quality Assurance & Regulatory Affairs at Candela Corporation from 2008 to 2011. Scott also held leadership roles at InfraReDx, Inc., Fossa Medical, and Medtronic AVE, where they gained extensive experience in manufacturing, quality assurance, and engineering management. Additionally, Scott served as a Member of the Board of Directors at MassMEDIC from 2010 to 2011.

Scott Blood attended Saint John's High School from 1982 to 1986. Scott then obtained further education at Wentworth Institute of Technology from 1986 to 1990. However, no specific degree or field of study is mentioned for either institution. Additionally, Scott Blood has obtained several certifications, including Certified Quality Auditor (CQA) from the American Society for Quality, Certified Quality Engineer (CQE) also from the American Society for Quality, and Regulatory Affairs Certification (RAC) - Devices from the Regulatory Affairs Professionals Society (RAPS). No specific dates of when these certifications were obtained are provided.